長期投資家のためのIR情報
バリュートレンド

【6190】フェニックスバイオ
PXBマウスを使った薬効試験受託。
類似企業:
【売上同水準】 リニカル WDBココ

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.03 2026/08/14 Q1予 1,610 → 0.0% 0.0% 85 → 0.0% 0.0% 87 → 0.0% 0.0% 76 → 0.0% 0.0%
2027.03 2026/05/15 当初予 1,610 - - - 85 - - - 87 - - - 76 - - -
2026.03 2026/05/15 実 1,565 ↓ -4.6% -11.0% 82 ↓ -24.8% -50.9% 131 ↑ +12.9% -22.0% 125 ↑ +13.6% -22.4%
2026.03 2026/02/13 Q3予 1,640 → 0.0% -6.8% 109 → 0.0% -34.7% 116 → 0.0% -31.0% 110 → 0.0% -31.7%
2026.03 2025/11/14 Q2予 1,640 ↓ -6.8% -6.8% 109 ↓ -34.7% -34.7% 116 ↓ -31.0% -31.0% 110 ↓ -31.7% -31.7%
2026.03 2025/08/14 Q1予 1,759 → 0.0% 0.0% 167 → 0.0% 0.0% 168 → 0.0% 0.0% 161 → 0.0% 0.0%
2026.03 2025/05/15 当初予 1,759 - - - 167 - - - 168 - - - 161 - - -
2025.03 2025/05/15 実 1,541 → 0.0% -27.3% -142 → 0.0% -166.4% -155 ↓ -2.6% -172.4% -448 ↓ -0.7% -322.9%
2025.03 2025/04/30 修正予 1,541 ↑ +1.3% -27.3% -142 ↑ +43.9% -166.4% -151 ↑ +45.5% -170.6% -445 ↓ -58.4% -321.4%
2025.03 2025/02/14 Q3予 1,521 → 0.0% -28.3% -253 → 0.0% -218.2% -277 → 0.0% -229.4% -281 → 0.0% -239.8%
2025.03 2024/11/14 Q2予 1,521 ↓ -28.3% -28.3% -253 ↓ -218.2% -218.2% -277 ↓ -229.4% -229.4% -281 ↓ -239.8% -239.8%
2025.03 2024/08/13 Q1予 2,121 → 0.0% 0.0% 214 → 0.0% 0.0% 214 → 0.0% 0.0% 201 → 0.0% 0.0%
2025.03 2024/05/15 当初予 2,121 - - - 214 - - - 214 - - - 201 - - -
2024.03 2024/05/15 実 1,715 ↓ -5.6% -15.8% 11 ↑ +37.5% -95.6% 43 ↓ -4.4% -82.8% 26 ↑ +8.3% -88.9%
2024.03 2024/02/14 Q3予 1,817 → 0.0% -10.8% 8 → 0.0% -96.8% 45 → 0.0% -82.0% 24 → 0.0% -89.8%
2024.03 2023/11/14 Q2予 1,817 ↓ -10.8% -10.8% 8 ↓ -96.8% -96.8% 45 ↓ -82.0% -82.0% 24 ↓ -89.8% -89.8%
2024.03 2023/08/14 Q1予 2,038 → 0.0% 0.0% 248 → 0.0% 0.0% 250 → 0.0% 0.0% 235 → 0.0% 0.0%
2024.03 2023/05/15 当初予 2,038 - - - 248 - - - 250 - - - 235 - - -
2023.03 2023/05/15 実 2,124 ↑ +5.1% +21.3% 508 ↑ +53.0% +146.6% 511 ↑ +57.2% +142.2% 493 ↑ +75.4% +149.0%
2023.03 2023/02/14 Q3予 2,021 ↑ +15.4% +15.4% 332 ↑ +61.2% +61.2% 325 ↑ +54.0% +54.0% 281 ↑ +41.9% +41.9%
2023.03 2022/11/14 Q2予 1,751 → 0.0% 0.0% 206 → 0.0% 0.0% 211 → 0.0% 0.0% 198 → 0.0% 0.0%
2023.03 2022/08/12 Q1予 1,751 → 0.0% 0.0% 206 → 0.0% 0.0% 211 → 0.0% 0.0% 198 → 0.0% 0.0%
2023.03 2022/05/13 当初予 1,751 - - - 206 - - - 211 - - - 198 - - -
2022.03 2022/05/13 実 1,324 ↑ +1.8% -17.1% -167 ↓ -7.7% -281.5% -127 ↑ +18.6% -239.6% -387 ↓ -146.5% -572.0%
2022.03 2022/02/14 Q3予 1,300 → 0.0% -18.6% -155 → 0.0% -268.5% -156 → 0.0% -271.4% -157 → 0.0% -291.5%
2022.03 2021/11/12 Q2予 1,300 ↓ -18.6% -18.6% -155 ↓ -268.5% -268.5% -156 ↓ -271.4% -271.4% -157 ↓ -291.5% -291.5%
2022.03 2021/08/13 Q1予 1,598 → 0.0% 0.0% 92 → 0.0% 0.0% 91 → 0.0% 0.0% 82 → 0.0% 0.0%
2022.03 2021/05/14 当初予 1,598 - - - 92 - - - 91 - - - 82 - - -
2021.03 2021/05/14 実 1,013 ↑ +2.1% -24.7% -276 ↑ +8.0% -452.0% -223 ↑ +18.3% -502.7% -238 ↑ +16.2% -510.3%
2021.03 2021/02/12 Q3予 992 ↓ -26.3% -26.3% -300 ↓ -500.0% -500.0% -273 ↓ -637.8% -637.8% -284 ↓ -628.2% -628.2%
2021.03 2020/11/13 Q2予 1,346 → 0.0% 0.0% -50 → 0.0% 0.0% -37 → 0.0% 0.0% -39 → 0.0% 0.0%
2021.03 2020/08/12 Q1予 1,346 - - - -50 - - - -37 - - - -39 - - -
2020.03 2020/05/15 修正予 1,310 ↓ -4.2% -22.3% -146 ↓ -67.8% -224.8% -125 ↓ -119.3% -191.2% -415 ↓ -603.4% -440.2%
2020.03 2020/02/14 Q3予 1,367 → 0.0% -19.0% -87 → 0.0% -174.4% -57 → 0.0% -141.6% -59 → 0.0% -148.4%
2020.03 2019/11/14 Q2予 1,367 ↓ -19.0% -19.0% -87 ↓ -174.4% -174.4% -57 ↓ -141.6% -141.6% -59 ↓ -148.4% -148.4%
2020.03 2019/08/09 Q1予 1,687 → 0.0% 0.0% 117 → 0.0% 0.0% 137 → 0.0% 0.0% 122 → 0.0% 0.0%
2020.03 2019/05/15 当初予 1,687 - - - 117 - - - 137 - - - 122 - - -
2019.03 2019/05/15 実 1,228 ↓ -3.8% -18.0% -311 ↓ -150.8% -350.8% -279 ↓ -146.9% -328.7% -297 ↓ -130.2% -385.6%
2019.03 2019/02/14 Q3予 1,277 → 0.0% -14.8% -124 → 0.0% -200.0% -113 → 0.0% -192.6% -129 → 0.0% -224.0%
2019.03 2018/11/14 Q2予 1,277 ↓ -14.8% -14.8% -124 ↓ -200.0% -200.0% -113 ↓ -192.6% -192.6% -129 ↓ -224.0% -224.0%
2019.03 2018/08/10 Q1予 1,498 → 0.0% 0.0% 124 → 0.0% 0.0% 122 → 0.0% 0.0% 104 → 0.0% 0.0%
2019.03 2018/05/15 当初予 1,498 - - - 124 - - - 122 - - - 104 - - -
2018.03 2018/05/15 実 902 ↓ -1.3% -39.1% -268 ↓ -7.2% -201.9% -267 ↓ -6.8% -201.9% -270 ↓ -6.3% -216.4%
2018.03 2018/03/15 修正予 914 ↓ -26.3% -38.2% -250 ↓ -580.8% -195.1% -250 ↓ -538.6% -195.4% -254 ↓ -629.2% -209.5%
2018.03 2018/02/14 Q3予 1,240 → 0.0% -16.2% 52 → 0.0% -80.2% 57 → 0.0% -78.2% 48 → 0.0% -79.3%
2018.03 2017/11/14 Q2予 1,240 → 0.0% -16.2% 52 → 0.0% -80.2% 57 → 0.0% -78.2% 48 → 0.0% -79.3%
2018.03 2017/10/17 修正予 1,240 ↓ -16.2% -16.2% 52 ↓ -80.2% -80.2% 57 ↓ -78.2% -78.2% 48 ↓ -79.3% -79.3%
2018.03 2017/08/10 Q1予 1,480 → 0.0% 0.0% 263 → 0.0% 0.0% 262 → 0.0% 0.0% 232 → 0.0% 0.0%
2018.03 2017/05/15 当初予 1,480 - - - 263 - - - 262 - - - 232 - - -
2017.03 2017/05/15 実 1,228 ↓ -3.5% -13.6% 142 ↓ -30.0% -59.9% 133 ↓ -26.1% -61.7% 128 ↓ -17.4% -57.2%
2017.03 2017/02/14 Q3予 1,273 → 0.0% -10.5% 203 → 0.0% -42.7% 180 → 0.0% -48.1% 155 → 0.0% -48.2%
2017.03 2016/11/14 Q2予 1,273 ↓ -10.5% -10.5% 203 ↓ -42.7% -42.7% 180 ↓ -48.1% -48.1% 155 ↓ -48.2% -48.2%
2017.03 2016/08/12 Q1予 1,422 → 0.0% 0.0% 354 → 0.0% 0.0% 347 → 0.0% 0.0% 299 → 0.0% 0.0%
2017.03 2016/05/13 当初予 1,422 - - - 354 - - - 347 - - - 299 - - -
2016.03 2016/05/13 実 1,217 - - - 190 - - - 149 - - - 125 - - -
シェア ツイート
ページトップへ戻る